- Agenus Announces Updated Phase 1 Data and Progress on BOT/BAL Development in Metastatic MSS Colorectal Cancer
- Agenus Announces Reverse Stock Split of Common Stock
- Agenus Reports Fourth Quarter and Full Year 2023 Results
- Agenus Announces Preclinical Data on BMS-986442 (AGEN1777) at AACR 2024
- Agenus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Agenus to Provide Corporate Update and Fourth Quarter & Full Year 2023 Financial Report
- Agenus to Participate in Leerink Partners Global Biopharma Conference
- Agenus to Participate in Oppenheimer 34th Annual Healthcare Life Sciences Conference
More ▼
Key statistics
On Friday, Agenus Inc (AGEN:NAQ) closed at 11.69, 144.82% above the 52 week low of 4.78 set on Apr 18, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 8.60 |
---|---|
High | 12.23 |
Low | 8.45 |
Bid | 11.78 |
Offer | 11.99 |
Previous close | 8.30 |
Average volume | 1.56m |
---|---|
Shares outstanding | 20.95m |
Free float | 20.69m |
P/E (TTM) | -- |
Market cap | 173.85m USD |
EPS (TTM) | -13.95 USD |
Data delayed at least 15 minutes, as of Apr 26 2024 21:00 BST.
More ▼